Literature DB >> 29845282

MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.

Xin Zhao1, Shicai Sun2, Jianting Xu3, Yang Luo4, Ying Xin5, Yanbing Wang1.   

Abstract

The function of microRNA‑152 for a cohort of patients with osteosarcoma and the influence on cell growth of osteosarcoma were studied. The expression of microRNA‑152 was downregulated in patients with osteosarcoma. The downregulation of microRNA‑152 promotes cell proliferation, decreases apoptosis, and suppresses LDH activity, caspase-3/9 activities and Bax/Bcl-2 and p53 protein expression levels of osteosarcoma through activation of the Wnt/β-catenin signaling pathway by targeting DKK1. Whereas, overexpression of microRNA‑152 targets DKK1 to inhibit cell proliferation, induce apoptosis, and promote LDH activity, caspase-3/9 activities and Bax/Bcl-2 and p53 protein expression levels of osteosarcoma through inactivation of the Wnt/β-catenin signaling pathway. The promotion of DKK1 reversed the anticancer function of microRNA‑152 over-expression through Wnt/β-catenin signaling pathway. We demonstrated that microRNA‑152 inhibits cell proliferation of osteosarcoma through DKK1 by directly targeting Wnt/β‑catenin signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29845282     DOI: 10.3892/or.2018.6456

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Molecular mechanism of microRNAs regulating apoptosis in osteosarcoma.

Authors:  Xueyang Cai; Wei Yin; Chao Tang; Yubao Lu; Yuqi He
Journal:  Mol Biol Rep       Date:  2022-04-26       Impact factor: 2.742

3.  microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.

Authors:  Weizhong Han; Xiaoxia Ren; Yupeng Yang; Haixia Li; Lin Zhao; Zhaoxia Lin
Journal:  Thorac Cancer       Date:  2020-05-04       Impact factor: 3.500

Review 4.  The Clinical Diagnostic and Prognostic Value of Dickkopf-1 in Cancer.

Authors:  Jie Li; Yan Gao; Wentao Yue
Journal:  Cancer Manag Res       Date:  2020-06-08       Impact factor: 3.989

5.  Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma.

Authors:  Kai Gao; Yingchun Zhang; Jianbing Niu; Zhikui Nie; Qingsheng Liu; Chaoliang Lv
Journal:  J Orthop Surg Res       Date:  2020-02-19       Impact factor: 2.359

6.  lncRNAS56464.1 as a ceRNA promotes the proliferation of fibroblast‑like synoviocytes in experimental arthritis via the Wnt signaling pathway and sponges miR‑152‑3p.

Authors:  Hui Jiang; Jian Liu; Chang Fan; Jing Wang; Weiping Li
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

Review 7.  Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy.

Authors:  Dimitri Papukashvili; Nino Rcheulishvili; Cong Liu; Fengfei Xie; Deependra Tyagi; Yunjiao He; Peng George Wang
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

8.  The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs.

Authors:  Mingxue Di; Yu Zhang; Renya Zeng; Xiaolin Liu; Weijia Chen; Meng Zhang; Cheng Zhang; Mengmeng Li; Mei Zhang
Journal:  Int J Biol Sci       Date:  2021-10-03       Impact factor: 6.580

Review 9.  Drug Discovery of DKK1 Inhibitors.

Authors:  Hewen Jiang; Zongkang Zhang; Yuanyuan Yu; Hang Yin Chu; Sifan Yu; Shanshan Yao; Ge Zhang; Bao-Ting Zhang
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

10.  Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1.

Authors:  Shenglong Li; Fei Liu; Yi Pei; Wei Wang; Ke Zheng; Xiaojing Zhang
Journal:  Aging (Albany NY)       Date:  2019-09-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.